. Author manuscript; available in PMC: 2025 Apr 1.

Published in final edited form as: Acad Radiol. 2023 Sep 27;31(4):1419–1428. doi: 10.1016/j.acra.2023.09.002

Table 2.

PSA and PSA doubling time values of each cohort and subgroups within.

	PSA (ng/ml) (mean ± std)	p-value	PSA doubling time (months) (mean ± std)	p-value
RP	2.49 ± 4.16		9.56 ± 10.28
Positive scan	3.02 ± 4.61	0.021	8.41 ± 7.79	0.046
Negative scan	1.14 ± 2.28	0.021	12.44 ± 14.53	0.046
Intrapelvic disease	1.76 ± 1.72	0.0001	9.45 ± 8.83	0.073
Extra-pelvic disease	5.59 ± 7.04	0.0001	6.33 ± 4.59	0.073
RT	6.74 ± 7.28		14.43 ± 14.77
Positive scan	7.12 ± 7.53	0.174	13.85 ± 13.75	0.330
Negative scan	3.18 ± 2.56	0.174	19.63 ± 22.81	0.330
Intrapelvic disease	5.67 ± 5.19	0.057	18.84 ± 15.38	0.0002
Extra-pelvic disease	9.30 ± 9.79	0.057	6.27 ± 4.94	0.0002